Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doruk Erkan

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2019
Is there a role for immunosuppression in antiphospholipid syndrome?Ecem Sevim, Rohan Willis, Doruk Erkan
Archives of Rheumatology|September 8, 2023
The ABCs of antiphospholipid syndromeAyşe Bahar Keleşoğlu Dinçer, Doruk Erkan
Autoimmunity Reviews|August 11, 2010
Catastrophic antiphospholipid syndrome: updated diagnostic algorithmsDoruk Erkan, Gerard Espinosa, Ricard Cervera
Thrombosis Research|July 17, 2017
Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome"Ayten Yazici, Ozan Unlu, Doruk Erkan
Pediatric Rheumatology Online Journal|April 26, 2024
The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patientsJheel Pandya, Karen Onel, Doruk Erkan
The Journal of Rheumatology|September 18, 2002
Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulatorArsinur Burcoglu-O'Ral, Doruk Erkan, Ronald Asherson
The Annals of Pharmacotherapy|November 22, 2013
Comment: discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparinSaif A Muhsin, Reena Khianey, Doruk Erkan
Rheumatic Diseases Clinics of North America|August 2, 2006
Cardiac manifestations in the antiphospholipid syndromeFelicia Tenedios, Doruk Erkan, Michael D Lockshin
Current Rheumatology Reports|September 8, 2019
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid SyndromeSarah Abramson Stoots, Lindsay Lief, Doruk Erkan
Arthritis and Rheumatism|October 15, 2003
Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse eventsYusuf Yazici, Doruk Erkan, Stephen A Paget
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Hematology. American Society of Hematology. Education Program|December 7, 2019
Is there a role for immunosuppression in antiphospholipid syndrome?Ecem Sevim, Rohan Willis, Doruk Erkan
Archives of Rheumatology|September 8, 2023
The ABCs of antiphospholipid syndromeAyşe Bahar Keleşoğlu Dinçer, Doruk Erkan
Autoimmunity Reviews|August 11, 2010
Catastrophic antiphospholipid syndrome: updated diagnostic algorithmsDoruk Erkan, Gerard Espinosa, Ricard Cervera
Thrombosis Research|July 17, 2017
Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome"Ayten Yazici, Ozan Unlu, Doruk Erkan
Pediatric Rheumatology Online Journal|April 26, 2024
The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patientsJheel Pandya, Karen Onel, Doruk Erkan
The Journal of Rheumatology|September 18, 2002
Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulatorArsinur Burcoglu-O'Ral, Doruk Erkan, Ronald Asherson
The Annals of Pharmacotherapy|November 22, 2013
Comment: discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparinSaif A Muhsin, Reena Khianey, Doruk Erkan
Rheumatic Diseases Clinics of North America|August 2, 2006
Cardiac manifestations in the antiphospholipid syndromeFelicia Tenedios, Doruk Erkan, Michael D Lockshin
Current Rheumatology Reports|September 8, 2019
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid SyndromeSarah Abramson Stoots, Lindsay Lief, Doruk Erkan
Arthritis and Rheumatism|October 15, 2003
Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse eventsYusuf Yazici, Doruk Erkan, Stephen A Paget
Pageof 20